Colorectal medullary carcinoma: heterogeneous presentations of a rare clinico-pathological entity. Report of two cases.


Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 22 3 2022
medline: 23 11 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

Colorectal medullary carcinoma (CMC) is a rare subset of minimally differentiated carcinomas. CMC tend to be right-sided and present at an advanced stage. Despite this, distant metastases are rare at presentation. The liver and the regional lymph nodes represent the most common sites of metastases. Most of the time, CMCs exhibit mismatch repair deficiency and a strong association with high-level microsatellite instability. There is no conspicuous data regarding treatment strategies and short-term outcomes. CMC is supposed to be related to better prognosis compared to poorly-differentiated and undifferentiated colonic adenocarcinomas, but reports are controversial.This lesion, with heterogeneous presentations and unclear prognostic significance, may be unfamiliar to histopathologists and can lead to diagnostic uncertainty and overtreatments.Our aim is to renew the attention to this rare histological subtype through the report of two cases.

Identifiants

pubmed: 35311395
doi: 10.1177/03008916221082996
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

NP20-NP25

Auteurs

Andrea Romanzi (A)

Department of General Surgery, Valduce Hospital, Como, Italy.

Giovanni Centonze (G)

First Pathology Unit, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan, Italy.

Giovanna Sabella (G)

First Pathology Unit, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan, Italy.

Laura Cattaneo (L)

First Pathology Unit, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan, Italy.

Carlo Battiston (C)

Gastrointestinal Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori Milano, Milan, Italy.

Nadia Di Lorenzo (ND)

Department of Pathology and Laboratory Medicine, Valduce Hospital, Como, Italy.

Maria Milanesi (M)

Department of General Surgery, Valduce Hospital, Como, Italy.

Antonella Putortì (A)

Department of General Surgery, Valduce Hospital, Como, Italy.

Fabrizio Rossi (F)

Department of General Surgery, Valduce Hospital, Como, Italy.

Roberta Scolaro (R)

Department of General Surgery, Valduce Hospital, Como, Italy.

Michel Zanardo (M)

Department of General Surgery, Valduce Hospital, Como, Italy.

Barbara Vignati (B)

Department of Clinical and Biomedical Sciences "Luigi Sacco", University of Milan, Milan, Italy.

Alberto Vannelli (A)

Department of General Surgery, Valduce Hospital, Como, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH